Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres

In a prospective multicenter phase II trial of radioembolization with yttrium-90 ((90)Y-RE) in chemorefractory liver-dominant metastatic colorectal cancer (mCRC), we showed that median survival was 12.6 months (95% CI 7.0–18.3) with 48% of 50 patients achieving disease control. In this extension ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Melucci, Elisa, Cosimelli, Maurizio, Carpanese, Livio, Pizzi, Giuseppe, Izzo, Francesco, Fiore, Francesco, Golfieri, Rita, Giampalma, Emanuela, Sperduti, Isabella, Ercolani, Cristiana, Sciuto, Rosa, Mancini, Raffaello, Garufi, Carlo, Diodoro, Maria Grazia, Mottolese, Marcella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602019/
https://www.ncbi.nlm.nih.gov/pubmed/23497522
http://dx.doi.org/10.1186/1756-9966-32-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602019/
https://www.ncbi.nlm.nih.gov/pubmed/23497522
http://dx.doi.org/10.1186/1756-9966-32-13

Ejemplares similares